Endolysosomal Cation Channels and Cancer—A Link with Great Potential

Pharmaceuticals - Tập 11 Số 1 - Trang 4
Christian Grimm1,2, Karin Bartel1, Angelika M. Vollmar1, Martin Biel1,2
1Department of Pharmacy, Center for Drug Research, Ludwig-Maximilians-Universität München, 81377 München, Germany
2Munich Center for Integrated Protein Science CIPSM, 81377 München, Germany

Tóm tắt

The endolysosomal system (ES) consists of lysosomes; early, late, and recycling endosomes; and autophagosomes. It is a key regulator not only of macromolecule degradation and recycling, plasma membrane repair, homeostasis, and lipid storage, but also of antigen presentation, immune defense, cell motility, cell death signaling, tumor growth, and cancer progression. In addition, it plays a critical role in autophagy, and the autophagy-lysosome pathway is intimately associated with the hallmarks of cancer, such as escaping cell death pathways, evading immune surveillance, and deregulating metabolism. The function of endolysosomes is critically dependent on both soluble and endolysosomal membrane proteins such as ion channels and transporters. Cation channels found in the ES include members of the TRP (transient receptor potential) channel superfamily, namely TRPML channels (mucolipins) as well as two-pore channels (TPCs). In recent studies, these channels have been found to play crucial roles in endolysosomal trafficking, lysosomal exocytosis, and autophagy. Mutation or loss of these channel proteins can impact multiple endolysosomal trafficking pathways. A role for TPCs in cancer cell migration and metastasis, linked to distinct defects in endolysosomal trafficking such as integrin trafficking, has been recently established. In this review, we give an overview on the function of lysosomes in cancer with a particular focus on the roles which TPCs and TRPML channels play in the ES and how this can affect cancer cells.

Từ khóa


Tài liệu tham khảo

Davidson, 2017, Critical Functions of the Lysosome in Cancer Biology, Annu. Rev. Pharmacol. Toxicol., 57, 481, 10.1146/annurev-pharmtox-010715-103101

Piao, 2016, Targeting the lysosome in cancer, Ann. N Y Acad. Sci., 1371, 45, 10.1111/nyas.12953

Saftig, 2013, Cancer: Killing from the inside, Nature, 502, 312, 10.1038/nature12692

Dingle, 1969, Lysosomes and cancer, Lysosomes in Biology and Pathology, Volume 2, 178

Allison, 1974, Lysosomes in cancer cells, J. Clin. Pathol. Suppl., 7, 43, 10.1136/jcp.27.Suppl_7.43

Dingle, 1973, Tumour lysosomal enzymes and invasive growth, Lysosomes in Biology and Pathology, Volume 3, 83

Fennelly, 2017, Lysosomal Biology in Cancer, Methods Mol. Biol., 1594, 293, 10.1007/978-1-4939-6934-0_19

Leanza, 2013, Intracellular ion channels and cancer, Front. Physiol., 4, 227, 10.3389/fphys.2013.00227

Peruzzo, 2016, Impact of intracellular ion channels on cancer development and progression, Eur. Biophys. J., 45, 685, 10.1007/s00249-016-1143-0

Gautier, 2014, New insights into pharmacological tools to TR(i)P cancer up, Br. J. Pharmacol., 171, 2582, 10.1111/bph.12561

Shapovalov, 2016, Role of TRP ion channels in cancer and tumorigenesis, Semin. Immunopathol., 38, 357, 10.1007/s00281-015-0525-1

Grimm, 2017, From mucolipidosis type IV to Ebola: TRPML and two-pore channels at the crossroads of endo-lysosomal trafficking and disease, Cell Calcium, 67, 148, 10.1016/j.ceca.2017.04.003

Nguyen, 2017, Two-pore channel function is crucial for migration of invasive cancer cells, Cancer Res., 77, 1427, 10.1158/0008-5472.CAN-16-0852

Nomura, 2005, Involvement of cathepsins in the invasion, metastasis and proliferation of cancer cells, J. Med. Investig., 52, 1, 10.2152/jmi.52.1

Mohamed, 2006, Cysteine cathepsins: Multifunctional enzymes in cancer, Nat. Rev. Cancer, 6, 764, 10.1038/nrc1949

Tardy, 2006, Lysosomes and lysosomal proteins in cancer cell death (new players of an old struggle), Biochim. Biophys. Acta, 1765, 101

Kallunki, 2013, Cancer-associated lysosomal changes: Friends or foes?, Oncogene, 32, 1995, 10.1038/onc.2012.292

Kirkegaard, 2009, Lysosomal involvement in cell death and cancer, Biochim. Biophys. Acta, 1793, 746, 10.1016/j.bbamcr.2008.09.008

Easton, 2006, mTOR and cancer therapy, Oncogene, 25, 6436, 10.1038/sj.onc.1209886

Nasrallah, 2017, Cancer: Linking Powerhouses to Suicidal Bags, Front. Oncol., 7, 204, 10.3389/fonc.2017.00204

Lopes, 2012, The mTOR signalling pathway in human cancer, Int. J. Mol. Sci., 13, 1886, 10.3390/ijms13021886

Brown, 1995, Role for phosphatidylinositol 3-kinase in the sorting and transport of newly synthesized lysosomal enzymes in mammalian cells, J. Cell Biol., 130, 781, 10.1083/jcb.130.4.781

Mousavi, 2003, Phosphoinositide 3-kinase regulates maturation of lysosomes in rat hepatocytes, Biochem. J., 372, 861, 10.1042/bj20021136

Collins, D., Chenard-Poirier, M., and Lopez, J. (2017). The PI3K pathway at the crossroads of cancer and the immune system: Strategies for next generation immunotherapy combinations. Curr. Cancer Drug Targets, 26.

LoPiccolo, 2008, Targeting the PI3K/Akt/mTOR pathway: Effective combinations and clinical considerations, Drug Resist. Updates, 11, 32, 10.1016/j.drup.2007.11.003

Wiedmann, 2012, The V-ATPase-inhibitor archazolid abrogates tumor metastasis via inhibition of endocytic activation of the Rho-GTPase Rac1, Cancer Res., 72, 5976, 10.1158/0008-5472.CAN-12-1772

Bartel, 2017, V-ATPase inhibition increases cancer cell stiffness and blocks membrane related Ras signaling—A new option for HCC therapy, Oncotarget, 8, 9476, 10.18632/oncotarget.14339

2016, Lysosomes in cancer-living on the edge (of the cell), Curr. Opin. Cell Biol., 39, 69, 10.1016/j.ceb.2016.02.009

Klinosky, 2016, Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition), Autophagy, 12, 1, 10.1080/15548627.2015.1100356

Landskron, 2014, Chronic inflammation and cytokines in the tumor microenvironment, J. Immunol. Res., 2014, 149185, 10.1155/2014/149185

Camoglio, 1998, Altered expression of interferon-gamma and interleukin-4 in inflammatory bowel disease, Inflamm. Bowel Dis., 4, 285, 10.1097/00054725-199811000-00005

Shacter, 2002, Chronic inflammation and cancer, Oncology, 16, 217

Coussens, 2002, Inflammation and cancer, Nature, 420, 860, 10.1038/nature01322

Bretou, 2017, Lysosome signaling controls the migration of dendritic cells, Sci. Immunol., 2, eaak9573, 10.1126/sciimmunol.aak9573

Chen, 2017, Small molecules for early endosome specific patch-clamping, Cell Chem. Biol., 24, 907, 10.1016/j.chembiol.2017.05.025

Sun, 2015, Novel Role of TRPML2 in the Regulation of the Innate Immune Response, J. Immunol., 195, 4922, 10.4049/jimmunol.1500163

Parrington, 2015, Calcium signals regulated by NAADP and two-pore channels—Their role in development, differentiation and cancer, Int. J. Dev. Biol., 59, 341, 10.1387/ijdb.150211jp

Huttenlocher, 2011, Integrins in cell migration, Cold Spring Harb. Perspect. Biol., 3, a005074, 10.1101/cshperspect.a005074

Paul, 2015, Endocytic Trafficking of Integrins in Cell Migration, Curr. Biol., 25, R1092, 10.1016/j.cub.2015.09.049

Grimm, 2014, High susceptibility to fatty liver disease in two-pore channel 2-deficient mice, Nat. Commun., 5, 4699, 10.1038/ncomms5699

Pafumi, 2017, Naringenin Impairs Two-Pore Channel 2 Activity and Inhibits VEGF-Induced Angiogenesis, Sci. Rep., 7, 5121, 10.1038/s41598-017-04974-1

Favia, 2014, VEGF-induced neoangiogenesis is mediated by NAADP and two-pore channel-2-dependent Ca2+ signaling, Proc. Natl. Acad. Sci. USA, 111, E4706, 10.1073/pnas.1406029111

Cang, 2013, mTOR regulates lysosomal ATP-sensitive two-pore Na+ channels to adapt to metabolic state, Cell, 152, 778, 10.1016/j.cell.2013.01.023

Laplante, 2009, mTOR signaling at a glance, J. Cell Sci., 122, 3589, 10.1242/jcs.051011

Li, 2016, Regulation of mTORC1 by lysosomal calcium and calmodulin, eLife, 5, e19360, 10.7554/eLife.19360

Medina, 2015, Lysosomal calcium signalling regulates autophagy through calcineurin and TFEB, Nat. Cell Biol., 17, 288, 10.1038/ncb3114

Palmieri, 2011, Characterization of the CLEAR network reveals an integrated control of cellular clearance pathways, Hum. Mol. Genet., 20, 3852, 10.1093/hmg/ddr306

Sardiello, 2009, A gene network regulating lysosomal biogenesis and function, Science, 325, 473, 10.1126/science.1174447

Haberkant, 2015, Intracellular sphingosine releases calcium from lysosomes, eLife, 4, e10616, 10.7554/eLife.10616

Medina, 2018, TRPML1: The Ca2+ retaker of the lysosome, Cell Calcium, 69, 112, 10.1016/j.ceca.2017.06.006

Marchand, 2015, Glycogen synthase kinase-3 (GSK3) inhibition induces prosurvival autophagic signals in human pancreatic cancer cells, J. Biol. Chem., 290, 5592, 10.1074/jbc.M114.616714

Giatromanolaki, 2015, Increased expression of transcription factor EB (TFEB) is associated with autophagy, migratory phenotype and poor prognosis in non-small cell lung cancer, Lung Cancer, 90, 98, 10.1016/j.lungcan.2015.07.008

Kors, 2016, Modelling TFE renal cell carcinoma in mice reveals a critical role of WNT signaling, eLife, 5, e17047, 10.7554/eLife.17047

Petit, 2012, The transcription factor TFEB links mTORC1 signaling to transcriptional control of lysosome homeostasis, Sci. Signal., 5, ra42

Perera, 2015, Transcriptional control of autophagy-lysosome function drives pancreatic cancer metabolism, Nature, 524, 361, 10.1038/nature14587

Settembre, 2013, TFEB controls cellular lipid metabolism through a starvation-induced autoregulatory loop, Nat. Cell Biol., 15, 647, 10.1038/ncb2718

Samie, 2013, A TRP channel in the lysosome regulates large particle phagocytosis via focal exocytosis, Dev. Cell, 26, 511, 10.1016/j.devcel.2013.08.003

Park, 2016, Fusion of lysosomes with secretory organelles leads to uncontrolled exocytosis in the lysosomal storage disease mucolipidosis type IV, EMBO Rep., 17, 266, 10.15252/embr.201541542

Ravi, 2016, Biphasic regulation of lysosomal exocytosis by oxidative stress, Cell Calcium, 60, 356, 10.1016/j.ceca.2016.08.002

Li, 2016, A molecular mechanism to regulate lysosome motility for lysosome positioning and tubulation, Nat. Cell Biol., 18, 404, 10.1038/ncb3324

Machado, 2015, Regulated lysosomal exocytosis mediates cancer progression, Sci. Adv., 1, e1500603, 10.1126/sciadv.1500603

Morelli, 2016, Overexpression of transient receptor potential mucolipin-2 ion channels in gliomas: Role in tumor growth and progression, Oncotarget, 7, 43654, 10.18632/oncotarget.9661